"Chong Hua Hospital is home of the region's top specialists and sub specialist. We are pleased to be the referral hospital of choice for physicians and patients seeking the highest level of quality healthcare. With our 660 beds and our state-of-the-art facilities and equipment, we are considered as one of the biggest, most advanced, fully integrated and comprehensive healthcare facility system in the Visayas and Mindanao. We are recognized by the Province and City of Cebu as an industry leader as well as commended by the Department of Health for rendering excellent services and facilities at par with those of the most respected hospitals in the world."

During the past decade, Chong Hua Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chong Hua Hospital" #1 sponsor was "Pfizer" with 6 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Philippine Neurological Association" with 2 trials sponsored and "Arcus Biosciences, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chong Hua Hospital" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Baguio General Hospital and Medical Center, Philippines" with 1 trials as a collaborator, "Chong Hua Hospital, Philippines" with 1 trials as a collaborator, "East Avenue Medical Center, Philippines" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Chong Hua Hospital" are "Arthritis, Rheumatoid" (3 trials), "Systemic Lupus Erythematosus" (3 trials), "Stroke" (2 trials), "Transient Ischemic Attack" (2 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Chong Hua Hospital" in a lesser frequency.

Most popular intervention types in "Chong Hua Hospital" are "Drug" (19 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (2 trials), "CP-690,550" (2 trials), "Abiraterone acetate (AA)" (1 trials) and "Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chong Hua Hospital" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Chong Hua Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Chong Hua Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Chong Hua Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".